Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "lopinavir" wg kryterium: Temat


Wyświetlanie 1-2 z 2
Tytuł:
X-ray diffraction and vibrational spectroscopic studies of the intermolecular interactions on the grinding and compaction behaviours of lopinavir and ritonavir crystals
Autorzy:
Ainurofiq, Ahmad
Setianto, Arif B.
Nugraha, Yuda P.
Suendo, Veinardi
Uekusa, Hidehiro
Soewandhi, Sundani N.
Powiązania:
https://bibliotekanauki.pl/articles/895537.pdf
Data publikacji:
2020-04-29
Wydawca:
Polskie Towarzystwo Farmaceutyczne
Tematy:
compression
grinding
Vibrational spectroscopy
Ritonavir
intermolecular interactions lopinavir
crystal behaviour
Opis:
Lopinavir (LPV) and ritonavir (RTV) are anti-viral drugs used in combination and commonly prepared through hot-melt extrusion techniques. Mechanical processes are greatly involved, including blending and milling. Therefore, the crystal behaviour of LPV and RTV under the mechanical process is an interesting study. Here, the LPV, RTV, and their mixtures were processed by two different treatments: grinding and compression processes. The solid-state properties of the drugs were evaluated by powder x-ray diffraction (PXRD), differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, and scanning electron microscopy (SEM). Single-crystal XRD analysis was also carried out to confirm the packing structure in the crystal lattice. It was observed that LPV was very sensitive to the grinding process, where it tends to form an amorphous solid in both the pure and mixture forms. On the other hand, RTV has a very stable crystalline structure and was able to retain its crystallinity even under grinding. Both LPV and RTV were observed to be quite stable under compression, where both retained their crystalline form with only slight changes in their d-spacing values. This study highlighted the molecular origin of LPV and RTV crystal behaviour after grinding and compression processes.
Źródło:
Acta Poloniae Pharmaceutica - Drug Research; 2020, 77, 2; 259-269
0001-6837
2353-5288
Pojawia się w:
Acta Poloniae Pharmaceutica - Drug Research
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Simultaneous determination of lopinavir, saquinavir and ritonavirin in human plasma using liquid chromatography – ion trap mass spectrometry
Autorzy:
Lipiński, Marcin
Bielawski, Krzysztof P.
Słomińska, Ewa M.
Smoleński, Ryszard T.
Powiązania:
https://bibliotekanauki.pl/articles/1891025.pdf
Data publikacji:
2021-12-02
Wydawca:
Gdański Uniwersytet Medyczny
Tematy:
antiviral therapy
lopinavir
saquinavir
ritonavir
LC/MS
Opis:
Background: Lopinavir, saquinavir, and ritonavir are viral protease inhibitors (PIs) developed for and widely used in the therapy of human immunodeficiency virus (HIV)-related disease. These compounds are also active in vitro against the pathogens causing tuberculosis, malaria and coronavirus infections. PIs have been regarded as a platform for the design of inhibitors targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-encoded proteases. This study aimed to develop a liquid chromatography/mass spectrometry (LC/MS) procedure for accurate simultaneous determination of concentrations of these three PIs in the plasma. Methods: Samples of human plasma were protein precipitated with 0.3 M zinc sulfate in a water/methanol solution (30:70, v/v). The extracts were analyzed with reversed-phase chromatography coupled with the electrospray ionization (ESI) source of the ion trap mass detector operating in mEass spectrometry (MS) and tandem mass spectrometry (MS/MS) modes. Results: Calibration curves demonstrated good linearity from 0.01 to 10 µg/mL and acceptable reproducibilities and recoveries. Conclusions: The described procedure proves that a very basic ion-trap LC/MS system could be applied for selective, rapid, and precise determination of antiviral protease inhibitors.
Źródło:
European Journal of Translational and Clinical Medicine; 2021, 4, 2; 60-67
2657-3148
2657-3156
Pojawia się w:
European Journal of Translational and Clinical Medicine
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies